Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tou tong ning capsule versus sodium valproate for vestibular migraine prophylaxis
ChiCTR-IPR-15007404Phase 4Recruiting
- Sponsor
- Navy General Hospital
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Toutongning and valproic acid in vestibular migraine (VM) (2 arms), sponsored by Navy General Hospital. Primary endpoint: Number of migraine attacks per month. Started Dec 2015; status: recruiting.
02
Drugs
Toutongningvalproic acid
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on ChiCTR-IPR-15007404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007404.